In both human psoriasis and murine models of psoriasiform inflammation, IL-23 is predominantly produced by myeloid DCs and promotes the expansion of pathogenic IL-17A-producing γδ T cells and CD4+ Th17 cells17,20,24. Here, IL17A is linked to psoriasis.